Salvus Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $702K | Sell |
8,051
-25
| -0.3% | -$2.18K | 0.41% | 68 |
|
|
2025
Q1 | $726K | Buy |
8,076
+170
| +2% | +$15.3K | 0.46% | 59 |
|
|
2024
Q4 | $632K | Sell |
7,906
-18
| -0.2% | -$1.44K | 0.4% | 66 |
|
|
2024
Q3 | $713K | Buy |
7,924
+100
| +1% | +$9K | 0.44% | 63 |
|
|
2024
Q2 | $616K | Sell |
7,824
-125
| -2% | -$9.84K | 0.42% | 64 |
|
|
2024
Q1 | $693K | Hold |
7,949
| – | – | 0.47% | 58 |
|
|
2023
Q4 | $655K | Buy |
7,949
+1,895
| +31% | +$156K | 0.47% | 60 |
|
|
2023
Q3 | $474K | Buy |
6,054
+115
| +2% | +$9.01K | 0.38% | 72 |
|
|
2023
Q2 | $523K | Buy |
5,939
+260
| +5% | +$22.9K | 0.4% | 68 |
|
|
2023
Q1 | $458K | Buy |
5,679
+875
| +18% | +$70.5K | 0.37% | 72 |
|
|
2022
Q4 | $373K | Buy |
4,804
+830
| +21% | +$64.5K | 0.34% | 75 |
|
|
2022
Q3 | $321K | Buy |
3,974
+40
| +1% | +$3.23K | 0.31% | 81 |
|
|
2022
Q2 | $353K | Buy |
3,934
+562
| +17% | +$50.4K | 0.32% | 78 |
|
|
2022
Q1 | $374K | Sell |
3,372
-20
| -0.6% | -$2.22K | 0.29% | 80 |
|
|
2021
Q4 | $351K | Buy |
3,392
+1,157
| +52% | +$120K | 0.26% | 80 |
|
|
2021
Q3 | $280K | Hold |
2,235
| – | – | 0.23% | 82 |
|
|
2021
Q2 | $282K | Sell |
2,235
-350
| -14% | -$44.2K | 0.24% | 77 |
|
|
2021
Q1 | $312K | Sell |
2,585
-50
| -2% | -$6.04K | 0.29% | 73 |
|
|
2020
Q4 | $315K | Buy |
+2,635
| New | +$315K | 0.34% | 69 |
|